Sorbent Therapeutics Secures $18,056,217 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=728fd2af-607f-4714-9ce2-fe49b1851fc1&Preview=1 -
Date
8/8/2012 -
Company Name
Sorbent Therapeutics -
Mailing Address
710 Lakeway Drive Sunnyvale, CA 94085 -
Company Description
Sorbent Therapeutics is a biopharmaceutical company focused on the development of adaptable non-absorbed polymeric drugs to satisfy unmet clinical needs in large markets such as End Stage Renal Disease (ESRD), Congestive Heart Failure (CHF), Chronic Kidney Disease (CKD), and Hypertension. -
Website
http://www.sorbentrx.com -
Transaction Type
Venture Equity -
Transaction Amount
$18,056,217 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
